Virustatic

Healthcare Technology
Seed Investment
2016-2021

Virustatic was a start-up company developing a ‘germ trap’ technology to apply to materials to prevent the spread of viruses, bacteria and fungus. The first application is a face mask/snood.

The business, which was given two small convertible loans from GM&C to help prove its technology, thrived due to the Covid pandemic, generating instant global demand for its snood product. The company also relocated to Alderley Park.

With little need to raise equity funding (triggering a loan conversion), Virustatic paid back its loans to GM&C, along with all interest. GM&C is now fully divested.

Our Approach

What do we look for?

Our business is about forming long term relationships with exceptional entrepreneurs and becoming a trusted partner and supportive investor.

We look for companies with both the vision and potential to become ‘game changers’ and market leaders across a range of sectors.

learn more

Our Team

Nick Wright

CEO

view complete team

Contact us

Tel: 01625 344300

email